Interstitial Lung Disease clinical trials
59 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
- A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Platform Clinical Study for Conquering Scleroderma
- A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
- A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
- Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
- Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
- Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
- Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Feasibility of Semaglutide in Advanced Lung Disease
- A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
- Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- Collagen-targeted PET Imaging for Early Interstitial Lung Disease
- Evaluation of Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74 PET/CT Imaging)
- Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients
- FAPI PET for Lung Fibrosis
- 129Xe MRI Cardiopulmonary
- MoblO2 to Maintain Oxygenation
- Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
- An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
- PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Dorothy P. and Richard P. Simmons Center for ILD Research Registry
- Pulmonary Fibrosis Foundation Community Registry
- Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)
- LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Cough Capture as a Portal Into the Lung
- Interstitial Lung Disease Research Unit Biobank
- SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
- MOBoxy: MoblO2 to Maintain Oxygenation
- A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
- Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Interstitial Lung Disease” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.